Rafoxanide and closantel inhibit SPAK and OSR1 kinases by binding to a highly conserved allosteric site on their C-terminal domains

  • Mubarak A. AlAmri
  • , Hachemi Kadri
  • , Luke J. Alderwick
  • , Nigel S. Simpkins
  • , Youcef Mehellou

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)639-645
    JournalChemMedChem
    Volume12
    Issue number9
    Early online date31 Mar 2017
    DOIs
    Publication statusPublished - 9 May 2017

    Bibliographical note

    Note: This work was supported by the Medical Research Council [reference: MC_PC_14107].

    Keywords

    • Biological sciences

    Cite this